Literature DB >> 11127684

Telangiectatic dedifferentiation of a parosteal osteosarcoma.

A Wines1, F Bonar, P Lam, S McCarthy, P Stalley.   

Abstract

A unique case of parosteal osteosarcoma (POS) of the proximal femur, with areas of telangiectatic dedifferentiation, in a 28-year-old woman is reported. The patient had a 7-week history of pain and swelling in her right thigh. A biopsy diagnosis of POS was established. The patient was treated with two cycles of intraarterial chemotherapy, followed by limb salvage surgery. Histological examination of the resected specimen showed POS with areas of dedifferentiation composed of highgrade telangiectatic osteosarcoma with associated secondary aneurysmal bone cyst change.

Entities:  

Mesh:

Year:  2000        PMID: 11127684     DOI: 10.1007/s002560000247

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  5 in total

1.  Parosteal osteosarcoma dedifferentiating into telangiectatic osteosarcoma: importance of lytic changes and fluid cavities at imaging.

Authors:  M Azura; D Vanel; M Alberghini; P Picci; E Staals; M Mercuri
Journal:  Skeletal Radiol       Date:  2009-03-07       Impact factor: 2.199

2.  Dedifferentiated parosteal osteosarcoma with giant cell tumor component.

Authors:  Diana M Cardona; Jacquelyn A Knapik; John D Reith
Journal:  Skeletal Radiol       Date:  2008-02-07       Impact factor: 2.199

3.  Telangiectatic osteosarcoma: a review of literature.

Authors:  Jun-Jian Liu; Shen Liu; Jian-Guang Wang; Wei Zhu; Ying-Qi Hua; Wei Sun; Zheng-Dong Cai
Journal:  Onco Targets Ther       Date:  2013-05-28       Impact factor: 4.147

4.  Parosteal Osteosarcoma: A Benign-Looking Tumour, Amenable to a Variety of Surgical Reconstruction.

Authors:  Yogi Prabowo; Achmad Fauzi Kamal; Evelina Kodrat; Marcel Prasetyo; Samuel Maruanaya; Toto Suryo Efar
Journal:  Int J Surg Oncol       Date:  2020-05-28

5.  Analysis of a Preliminary microRNA Expression Signature in a Human Telangiectatic Osteogenic Sarcoma Cancer Cell Line.

Authors:  Gaia Palmini; Cecilia Romagnoli; Simone Donati; Roberto Zonefrati; Gianna Galli; Francesca Marini; Teresa Iantomasi; Alessandra Aldinucci; Gigliola Leoncini; Alessandro Franchi; Giovanni Beltrami; Domenico Andrea Campanacci; Rodolfo Capanna; Maria Luisa Brandi
Journal:  Int J Mol Sci       Date:  2021-01-25       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.